Dr. Keefer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 N Wolfe St
Baltimore, MD 21287Phone+1 410-955-6132
Education & Training
- Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1999 - 2003
- Johns Hopkins UniversityResidency, Pediatrics, 1996 - 1999
- Vanderbilt University School of MedicineClass of 1996
Certifications & Licensure
- MD State Medical License 2003 - 2026
Clinical Trials
- A Phase II Trial of Regadenoson in Sickle Cell Anemia Start of enrollment: 2013 Jul 01
Publications & Presentations
PubMed
- 6 citationsClinical evaluation of combined azacitidine and entinostat on the induction of fetal hemoglobin in patients with acute myeloid leukemias and myelodysplastic syndromes.Katharine R. Press, Natalie Uy, Jeffrey R. Keefer, Steven D. Gore, Hetty E. Carraway
Leukemia & Lymphoma. 2018-03-04 - 6 citationsIdentification of Aptamers That Bind to Sickle Hemoglobin and Inhibit Its PolymerizationShirley H. Purvis, Jeffrey R. Keefer, Yolanda M. Fortenberry, Emily Barron-Casella, James F. Casella
Nucleic Acid Therapeutics. 2017-12-01 - 8 citationsCorrection to A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia [The Journal of Experimental Medicine...Michael A. McDevitt, Jianlin Xie, Shanmugasundaram Ganapathy-Kanniappan, Jason W. Griffith, Aihua Liu
The Journal of Experimental Medicine. 2015-05-04
Press Mentions
- ASCO ’22 Preview: Putting Patients FirstJune 1st, 2022
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/jeffrey-keefer
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: